MedPath

Nerve Growth Factor in Chronic Pancreatitis

Completed
Conditions
Chronic Pancreatitis
Registration Number
NCT01255917
Lead Sponsor
Virginia Commonwealth University
Brief Summary

This study is to understand the role of nerve growth factor(NGF) and other cytokines in the pancreatic fluid of patients with chronic pancreatitis.

Hypothesis:

1. Pain does not correlate with changes in the PD morphology suggesting that pain in CP is not only a mechanical problem

2. Pain in CP correlates better with the levels of NGF in the pancreatic juice. NGF is variably expressed in different morphological stages of CP and regulates the sensitivity of the peptidergic nociceptors and is upregulated in pancreatic inflammation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
38
Inclusion Criteria
  • Patients with established CP and none of the exclusion criteria mention below.
Exclusion Criteria
  • Failure to obtain consent.
  • Any comorbid condition with expected survival < 1 year.
  • Patients with pacemaker, implanted metallic prosthesis or other contraindications to do MRCP.
  • Patients < 18 years of age at time of consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The levels of NGF in subjects with different morphological stages of chronic pancreatitis (CP) will be compared to the controls and in each morphological stage of CP will be correlated with pain scores.5 years
Secondary Outcome Measures
NameTimeMethod
Correlate the expression of NGF and other inflammatory cytokines in the pancreatic juice in each morphological stage of CP.5 years

Trial Locations

Locations (1)

Virginia Commonwealth University Medical Center

🇺🇸

Richmond, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath